Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score

Amanda Mocroft, Bruno Ledergerber, Kai Zilmer, Ole Kirk, Bernard Hirschel, Jean-Paul Viard, Peter Reiss, Patrick Francioli, Adriano Lazzarin, Ladislav Machala, Andrew N Phillips, Jens D Lundgren, EuroSIDA study group and the Swiss HIV Cohort Study

37 Citations (Scopus)

Abstract

To derive and validate a clinically applicable prognostic score for predicting short-term disease progression in HIV-infected patients taking combination antiretroviral therapy (cART).
Original languageEnglish
JournalAIDS
Volume21
Issue number14
Pages (from-to)1867-1875
Number of pages9
ISSN0269-9370
DOIs
Publication statusPublished - 2007

Keywords

  • Acquired Immunodeficiency Syndrome
  • Adult
  • Anemia
  • Anti-Retroviral Agents
  • Body Mass Index
  • CD4 Lymphocyte Count
  • Disease Progression
  • Drug Therapy, Combination
  • Female
  • HIV Infections
  • HIV Seropositivity
  • HIV-1
  • Humans
  • Male
  • Prognosis
  • Prospective Studies
  • Reproducibility of Results
  • Risk Assessment
  • Viral Load

Fingerprint

Dive into the research topics of 'Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score'. Together they form a unique fingerprint.

Cite this